For the quarter ending 2025-12-31, CAH had -$1,816M decrease in cash & cash equivalents over the period. $555M in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net earnings/(loss) | 471 | 454 | 243 | 508 |
| Depreciation and amortization | 234 | 233 | 209 | 207 |
| Gain (loss) on sale of investments | - | 5 | - | - |
| Impairments and loss on sale of other investments | -5 | - | -1 | 0 |
| Impairments and (gain)/loss on disposal of assets, net | 14 | -2 | -33 | 17 |
| Share-based compensation | 87 | 93 | 153 | 31 |
| Provision for/(benefit from) deferred income taxes | - | - | 243 | - |
| Provision for bad debts | 14 | 13 | 12 | 13 |
| Increase in trade receivables | -341 | 539 | 466 | 114 |
| Increase in inventories | 2,543 | 736 | 607 | -758 |
| Increase/(decrease) in accounts payable | 2,029 | 2,147 | 1,778 | 1,424 |
| Repurchases of liability-classified units | 22 | - | - | - |
| Other accrued liabilities and operating items, net | -89 | 699 | 72 | -107 |
| Net cash provided by/(used in) operating activities | 686 | 973 | 1,527 | 2,917 |
| Acquisition of subsidiaries, net of cash acquired | 1,884 | 41 | 1,395 | 2,779 |
| Proceeds from divestitures, net of cash sold | - | - | - | 0 |
| Additions to property and equipment | 131 | 108 | 232 | 126 |
| Proceeds from disposal of property and equipment | 28 | - | - | 3 |
| Purchases of investments | - | - | - | 3 |
| Proceeds from investments | - | - | - | 5 |
| Proceeds from net investment hedge terminations | - | - | 0 | 2 |
| Purchase of short-term time deposits | - | - | 0 | 0 |
| Proceeds from short-term investment in time deposit | 0 | - | 0 | 0 |
| Increase (decrease) in other investing items, net | 4 | 7 | 2 | - |
| Net cash used in investing activities | -1,980 | -142 | -1,631 | -2,898 |
| Proceeds from debt, net of issuance costs | - | 989 | 3,669 | - |
| Proceeds from long-term obligations, net of issuance costs | -150 | - | - | 1,139 |
| Reduction of long-term obligations | 12 | 512 | 11 | 11 |
| Payments to noncontrolling interests | 1 | 3 | 12 | - |
| Net tax withholding from share-based compensation | -1 | -80 | -1 | 3 |
| Dividends on common shares | 122 | 129 | 120 | 124 |
| Purchase of treasury shares, net | 383 | 375 | 0 | 375 |
| Net cash provided by/(used in) financing activities | -519 | -110 | 656 | -507 |
| Effect of exchange rate on cash, cash equivalent, restricted cash, and restricted cash equivalent, continuing operation | -3 | -2 | -4 | 4 |
| Net decrease in cash and equivalents | -1,816 | 719 | 548 | -484 |
| Cash and cash equivalents at beginning of period | 4,593 | 3,874 | 3,326 | 3,810 |
| Cash and cash equivalents at end of period | 2,777 | 4,593 | 3,874 | 3,326 |
CARDINAL HEALTH INC (CAH)
CARDINAL HEALTH INC (CAH)